Especially, past meta-analyses of genome-wide association studies (GWAS) targeting sporadic PD have repeatedly identified two of the above familial PD genes—LRRK2 and SNCA—as major risk factors, indicating that the impact of these two genes is more common in the general population (9–11). The gene discussed is LRRK2; the disease is Parkinson disease.